SMi's 3D Cell Culture conference 2020 – Speakers announced

SMi Reports: Agenda and speaker overview of the upcoming 4th Annual 3D Cell Culture Conference 2020, in London
By: SMi Group
 
 
P-310-3D-Cell-Culture-2020-banner-650x650
P-310-3D-Cell-Culture-2020-banner-650x650
 
Spread the Word
Listed Under

Tag:
3D cell culture

Industry:
Medical

Location:
London City - London, Greater - England

Subject:
Events

LONDON - Oct. 15, 2019 - PRLog -- SMi Group is delighted to announce the return of the successful 3D Cell Culture Conference for its 4th year, on 19th and 20th February 2020 in London. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, safety and toxicity.

The two-day agenda will focus on 'Development and application of human organs and tissues in vitro' which explores advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field.

This year, the conference will be co-chaired by Philip Hewitt, UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA and Stefan Przyborski, Professor of Cell Technology, Durham University

For those interested in attending, there is an early bird offer with £400 savings for bookings made by 31st October, www.3D-cellculture.com/PR1

Key Featured speakers include:
•          Leonard Both, Senior Quality Assessor, Biologicals/Biotechnology Unit, MHRA
•          Veronique Barban, Expert Virology, Research and Nonclinical Safety Department, Sanofi Pasteur
•          Simone Stahl, Associate Principal Scientist, ADME Sciences, Clinical Pharmacology and Safety Sciences, AstraZeneca
•          Wendy Rowan, Scientific Director, Novel Human Genetics Research Unit, GSK
•          Jason Ekert, Head of Complex In Vitro Models, GSK
•          Samuel Jackson, Programme Manager, Disease Models Efficacy and Safety Pharmacology, NC3RS

In addition to the agenda, a '3D Bioprinting' Focus Day will be held on 18th February 2020, led by prominent expert speakers. The focus day will explore case studies from big pharma, biotech's and academia exploring how bioprinting is being used, highlighting projects looking at stem cell therapy, drug screening and extracellular matrix scaffolds.

Topics covered will include:
•          Learn how leaders in big Pharma are incorporating bioprinting into cell culture research
•          Explore novel applications of 3D bioprinting for in vitro models and regenerative medicine
•          Network with the leading pharmaceutical and biotech companies developing the use of bioprinting with the pharma industry

For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk

3D Cell Culture 2020
Focus Day: 18 February 2020
Conference: 19th - 20th February 2020
Copthorne Tara Hotel, London
https://www.smi-online.co.uk/pharmaceuticals/uk/3D-Cell-Culture
#SMi3DCellCulture

Contact
SMi Pharma
Simi Sapal
***@smi-online.co.uk
End
Email:***@smi-online.co.uk Email Verified
Tags:3D cell culture
Industry:Medical
Location:London City - London, Greater - England
Subject:Events
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share